Stock Updates

Today’s Top Gainers in the Market Sanofi (NYSE:SNY) from Healthcare

Today’s top gainers include the company Sanofi (NYSE:SNY) which is in the industry Drug Manufacturers – Major, gaining -0.14% today. In the last week its performance is 8.69%, and 4.08% for the past quarter. Currently, Sanofi, SNY has a target price of 52, so today’s gain of -0.14% is a significant step towards its target price. The GAP today is therefore -0.24%.

Sanofi (NYSE:SNY), has a market cap of 107248.19, and is based in France. Insider ownership is at 16.40%, and institutional ownership is 9.70%.

At the current price of 41.79, it has a dividend yield of 3.97%, and its target price is 52. This is with a profit margin of *TBA, and total debt/equity of *TBA. Sanofi (NYSE:SNY) has a P/E of 22.29, as well as a forward P/E of 13.2.

With a current EPS of 1.88, and a forecasted EPS growth for next year at 0.16%,Sanofi (NYSE:SNY) has had a EPS growth for the past five years at -4.40%. For the next five years EPS growth is projected to be 7.10%.

Performance for the year is -11.97%. Since its IPO date on 07/01/2002, the total performance to date is 2.11%.

Volume today for Sanofi (NYSE:SNY), is 3431456, while its average volume is 2136.92. Whilst the total gain today was -0.14%, it did have a day high of -2.14%.

Volatility for this week has been at 1.59%, and 1.64% for the month. The 52-week low for Sanofi, SNY has been 15.73%, while the 52-week-high has reached -20.79%.

Looking at its return of investments, which is 6.50%, and its return on assets is *TBA. Sanofi (NYSE:SNY) has an operating margin of *TBA. With a sales growth of -3.60% quarter over quarter. Bearing in mind that Sanofi, SNY is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.

So what is the value of Sanofi? Well its PEG is 3.14, and the P/S is 2.79, along with a P/B of 1.7. Meanwhile it has a p/cash of *TBA.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment